A COVID-19 study done at the University of Virginia (UVA) has the potential to create new treatment approaches for chronic ...

At a time when the world seems eager to declare the COVID-19 pandemic a closed chapter, I — along with millions of other Americans — continue to confront a relentless, invisible enemy that has ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

In the Covid years, respiratory viruses hit an all-time low ... efficiently warding off infections and helping us minimise unwanted inflammation and chronic disease. There is no single way to support ...

MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be ...

Three years on, Dr. Allison Cohen still can't run or take long drives without feeling sick. With no standard test or ...

They're pushing for more funding to find effective treatments. Researchers are finally starting to make headway but have a ...

Treatment with HU6 led to significant reductions in body fat and abdominal visceral fat while preserving skeletal muscle in patients with obesity-related heart failure with preserved ejection fraction ...

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute ...

That was the same time the Washington Post ran the story “ NIH reels with fear, uncertainty about future of scientific ...